Skip to content

Regenxbio RGNX Common Stock

Common Stock at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$11K+10.0%
Biogen logo
BiogenBIIB
$100K0.0%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
500M0.0%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$83K+20.3%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$0-100%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$5K0.0%

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's common stock?
Regenxbio (RGNX) reported common stock of $5K in Q1 2026.
How has Regenxbio's common stock changed year-over-year?
Regenxbio's common stock decreased by 0.0% year-over-year, from $5K to $5K.
What is the long-term trend for Regenxbio's common stock?
Over 5 years (2020 to 2025), Regenxbio's common stock has grown at a 4.6% compound annual growth rate (CAGR), from $4K to $5K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).